JAMA 325 (1): 50-58, 2021.[PUBMED Abstract] Masuda N, Lee SJ, Ohtani S, et al.: Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy.
N Engl J Med 376 (22): 2147-2159, 2017.[PUBMED Abstract] Ignatiadis M, Bailey A, McArthur H, et al.: Adjuvant Atezolizumab for Early Triple-Negative Breast Cancer: The ALEXANDRA/IMpassion030 Randomized Clinical Trial.
JAMA 333 (13): 1150-60, 2025.[PUBMED Abstract] Buzdar AU, Ibrahim NK, Francis D, et al.: Significantly higher pathologic complete remission rate after neoadjuvant therapy with trastuzumab, paclitaxel, and epirubicin chemotherapy: results of a randomized trial in human epidermal growth factor receptor 2-positive operable breast cancer.